ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,036.69
0.36%
Dow Jones
38,005.41
0.27%
US Dollar vs MXN
16.94115
-0.01%
Brent Oil
83.595
0.07%
Bitcoin
58,341.15
0.17%
Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Corcept Therapeutics Inc (CORT)

  7. Corcept Therapeutics Inc (CORT) Noticias

CORT Corcept Therapeutics Inc

24.47
0.59 (2.47%)
Última actualización: 08:32:42
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Corcept Therapeutics Inc CORT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.59 2.47% 24.47 08:32:42
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
26.39 24.47 26.39 23.88
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202415:05GLOBECorcept Therapeutics Announces First Quarter Financial..
29/4/202407:00GLOBECorcept Completes Enrollment in Phase 4 CATALYST Trial
24/4/202415:05GLOBECorcept Therapeutics to Announce First Quarter Financial..
22/4/202407:00GLOBECorcept Announces Positive Results From Open-Label Portion..
15/4/202407:00GLOBECorcept Completes Enrollment in Phase 2 DAZALS Trial in..
08/4/202407:00GLOBECorcept Completes Enrollment in Pivotal Phase 3 Rosella..
01/4/202407:00GLOBECorcept Completes Enrollment in Phase 3 Gradient Trial of..
05/3/202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202420:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202419:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/3/202416:24EDGAR2Form 144 - Report of proposed sale of securities
21/2/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/2/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202411:12EDGAR2Form 144 - Report of proposed sale of securities
15/2/202415:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
15/2/202415:11EDGAR2Form 8-K - Current report
15/2/202415:07GLOBECorcept Therapeutics Announces Fourth Quarter and Full-Year..
15/2/202415:02GLOBECorcept Announces Preliminary Results From Prevalence Phase..
15/2/202414:45EDGAR2Form 144 - Report of proposed sale of securities
14/2/202415:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202419:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202418:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202415:46EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
12/2/202418:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:05GLOBECorcept Therapeutics to Announce Fourth Quarter and..
02/2/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202413:17EDGAR2Form 144 - Report of proposed sale of securities
29/1/202407:00GLOBECorcept Appoints Roberto Vieira as President, Oncology
22/1/202414:52EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/1/202419:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:06EDGAR2Form 8-K - Current report
08/1/202407:00GLOBECorcept Therapeutics Provides Financial Update and Announces..
04/1/202418:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202410:24EDGAR2Form 144 - Report of proposed sale of securities
02/1/202407:06EDGAR2Form 8-K - Current report
02/1/202407:00GLOBECourt Finds Corcept Therapeutics’ Patents Not Infringed
22/12/202318:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202311:09EDGAR2Form 144 - Report of proposed sale of securities
19/12/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202320:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202319:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202315:34EDGAR2Form 8-K - Current report

Su Consulta Reciente

NASDAQ
CORT
Corcept Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados